It can't be completely invalid, not since the FDA would also be making the exact same comparisons when considering Veyonda for approval as an add-on treatment, along with the data generated by NOX.
- Forums
- ASX - By Stock
- Ann: New Independent Trial Data Supports Potential of Veyonda
NOX
noxopharm limited
Add to My Watchlist
2.08%
!
4.7¢

It can't be completely invalid, not since the FDA would also be...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.7¢ |
Change
-0.001(2.08%) |
Mkt cap ! $14.02M |
Open | High | Low | Value | Volume |
4.8¢ | 4.8¢ | 4.7¢ | $6.448K | 137.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 4.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.7¢ | 67244 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.046 |
3 | 35080 | 0.045 |
1 | 70000 | 0.044 |
1 | 50000 | 0.043 |
1 | 24390 | 0.041 |
Price($) | Vol. | No. |
---|---|---|
0.047 | 67244 | 2 |
0.048 | 20000 | 1 |
0.049 | 139316 | 2 |
0.057 | 10730 | 1 |
0.061 | 16393 | 1 |
Last trade - 11.05am 10/07/2025 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |